Serum Institute gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine https://ift.tt/eA8V8J

Drugs Controller General of India (DCGI) V.G. Somani has gave permission to Serum Institute of India (SII) to resume clinical trial of the Oxford COV

from The Hindu - National https://ift.tt/3c0iBqr